// App-Quantinova.ai

149 : Predictors of Long-Term Retention of Anti-TNF Treatment: An Analysis from a Prospective, Observational Registry.

Researchers

Presenter

  • Philip Baer

Principal Investigators

  • Mary Bell

  • Francois Nantel

  • Brendan Osborne

  • Cathy Tkaczyk

  • Karina Maslova

  • Andrew Chow

  • Louis Bessette

  • Boulos Haraoui

  • Wojciech Olszynski

  • John Kelsall

  • Emmanouil Rampakakis

  • John Sampalis

  • Allen Lehman

Medical Centers

  • Credit Valley Rheumatology, Mississauga, ON, Canada

  • Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • Centre de recherche du CHU de Quebec, Universite Laval, Quebec,Canada

  • Univ of Toronto, Toronto, Canada

  • Institut de Rhumatologie, Montreal, QC, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved